Document is current
Any future updates will be listed below
-
Authors
Chu, Ming
Zhang, Shimeng
Gong, Jinlong
Yang, Shu
Yang, Gang
Sun, Xingxing
Wu, Dan
Xia, Yaodongqin
Jiao, Jincheng
Peng, Xiafeng
Peng, Zhihang
Hong, Li
Wang, Zhirong
Li, Mingfang https://orcid.org/0000-0001-8755-6965
Lip, Gregory Y. H. https://orcid.org/0000-0002-7566-1626
Chen, Minglong https://orcid.org/0000-0002-9844-486X
,
Guo, Yutao
Liu, Xinfeng
Lu, Shanshan
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 14 January 2025
First Online: 21 February 2025
Competing interests
: G.Y.H.L. is a consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo and Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) senior investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF (grant agreement no. 899871), TARGET project on digital twins for personalized management of AF and stroke (grant agreement no. 101136244) and ARISTOTELES project on artificial intelligence for the management of chronic long-term conditions (grant agreement no. 101080189), which are all funded by the European Union’s Horizon Europe research and innovation program. The other authors declare no competing interests.
